The dual inhibitor of the phosphoinositol ‐3 and PIM kinases, IBL‐202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - July 6, 2018 Category: Hematology Authors: Kyle Crassini , Yandong Shen , Michael O'Dwyer , Michael O'Neill , Richard Christopherson , Stephen Mulligan , O. Giles Best Source Type: research